The Georgia Opioid Settlement Advisory Commission has endorsed how the initial portion of a significant $638 million settlement with opioid manufacturers and distributors should be utilized. $44. 4 million has been designated for 130 projects in the first year of a 20-year initiative, focusing on treatment, prevention, naloxone availability, and research to address the opioid crisis. Opioid overdose deaths have decreased nationwide for the first time since 2018, including in Georgia. The high demand for funding resulted in over 300 applications totaling $248 million, with the current distribution process involving regional boards and a trustee, Kevin Tanner. The aim is to finalize grants by the end of the year and start the next grant application cycle in the spring. The funding, which includes $638 million overall, will be mostly distributed through the grant process, with $159 million going to the city of Atlanta and major Georgia counties through a separate process. This funding originates from a $26 billion settlement with major pharmaceutical distributors and manufacturers like Johnson & Johnson.